<qa>  What is the goal of the current study?The objective of the current study is to demonstrate bioequivalence of two 2.5 mg linagliptin500 mg metformin fixed dose combination tablets compared to the free combination of the linagliptin 5 mg and metformin 1000 mg in healthy male and female volunteers. 